Metropolis Healthcare Ltd.
BSE: 542650 | Sector: Health care |
NSE: METROPOLIS | ISIN Code: INE112L01020 |
BSE 00:00 | 04 Mar | 1963.20 |
-14.10 (-0.71%) |
OPEN
1967.85 |
HIGH
1993.85 |
LOW
1954.55 |
NSE 00:00 | 04 Mar | 1962.00 |
-11.70 (-0.59%) |
OPEN
1972.50 |
HIGH
1994.45 |
LOW
1960.00 |
OPEN | 1967.85 |
PREVIOUS CLOSE | 1977.30 |
VOLUME | 5253 |
52-Week high | 2321.00 |
52-Week low | 993.20 |
P/E | 69.94 |
Mkt Cap.(Rs cr) | 10,032 |
Buy Price | 1960.10 |
Buy Qty | 1.00 |
Sell Price | 1975.00 |
Sell Qty | 33.00 |
Metropolis Healthcare Ltd. (METROPOLIS) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Aurobindo Pharma | 874.50 | -6.30 | -0.72 | 13266.48 |
Cipla | 806.20 | -6.10 | -0.75 | 12659.15 |
Sun Pharma.Inds. | 618.65 | -5.50 | -0.88 | 12531.93 |
Dr Reddy's Labs | 4574.30 | 73.50 | 1.63 | 11850.40 |
Lupin | 1048.15 | -12.70 | -1.20 | 11025.66 |
Apollo Hospitals | 3043.45 | -14.70 | -0.48 | 9794.50 |
Glenmark Pharma. | 474.00 | -5.00 | -1.04 | 6712.63 |
Alkem Lab | 2827.20 | -13.70 | -0.48 | 6677.08 |
Cadila Health. | 449.00 | 3.50 | 0.79 | 6347.40 |
Torrent Pharma. | 2497.80 | 0.35 | 0.01 | 6168.44 |
Divi's Lab. | 3554.30 | -10.80 | -0.30 | 5310.57 |
Ipca Labs. | 1931.15 | -30.10 | -1.53 | 4337.82 |
Piramal Enterp. | 1956.90 | -35.80 | -1.80 | 4219.19 |
Alembic Pharma | 922.00 | -7.20 | -0.77 | 4132.55 |
Abbott India | 14646.00 | 36.95 | 0.25 | 4093.14 |
Glaxosmi. Pharma | 1541.65 | 17.15 | 1.12 | 3224.68 |
Jubilant Pharmo | 783.70 | -5.70 | -0.72 | 3139.90 |
Sanofi India | 8326.90 | 33.10 | 0.40 | 3070.60 |
Laurus Labs | 368.35 | 3.75 | 1.03 | 2797.34 |
Gland Pharma | 2671.10 | 238.40 | 9.80 | 2633.24 |
Quick Links for Metropolis Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices